Earnings Feed
Start Free
Home/Filings/4/0001079974-15-000251
4//SEC Filing

OMNI BIO PHARMACEUTICAL, INC. 4

Accession 0001079974-15-000251

CIK 0001389870operating
View on SEC.govCompany Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 6:02 PM ET

Size

22.1 KB

Accession

0001079974-15-000251

Insider Transaction Report

Form 4
Period: 2014-04-18
OMNI BIO PHARMACEUTICAL, INC.OMBP
BOCO Investments LLC
10% Owner
Transactions
  • Purchase

    Common

    2015-02-27$0.25/sh+2,998,678$749,670→ 10,132,678 total
  • Purchase

    Warrant

    2014-04-18+3,000,000→ 10,350,000 total
    Exercise: $0.01From: 2014-04-18Exp: 2015-04-15→ Common Stock (3,000,000 underlying)
  • Exercise of In-Money

    Warrant

    2015-02-27$0.01/sh−3,000,000$30,000→ 4,950,000 total
    Exercise: $0.01From: 2014-04-18Exp: 2015-04-15→ Common Stock (3,000,000 underlying)
  • Conversion

    Convertible Note

    2015-02-27$0.25/sh−2,400,000$600,000→ 7,950,000 total
    Exercise: $0.25From: 2012-10-31Exp: 2015-10-31→ Common Stock (2,998,678 underlying)
  • Other

    Warrant

    2014-04-18+2,900,000→ 7,350,000 total
    Exercise: $0.25From: 2009-03-31Exp: 2019-12-31→ Common Stock (2,900,000 underlying)
  • Other

    Warrant

    2014-04-18−1,450,000→ 7,350,000 total
    Exercise: $0.25From: 2009-03-31Exp: 2017-03-31→ Common Stock (1,450,000 underlying)
  • Other

    Warrant

    2014-04-18+1,450,000→ 7,350,000 total
    Exercise: $0.25From: 2009-03-31Exp: 2019-12-31→ Common Stock (1,450,000 underlying)
  • Purchase

    Common

    2015-02-27$0.01/sh+3,000,000$30,000→ 13,132,678 total
  • Other

    Warrant

    2014-04-18−2,900,000→ 7,350,000 total
    Exercise: $0.25From: 2009-03-31Exp: 2017-03-31→ Common Stock (2,900,000 underlying)
Footnotes (3)
  • [F1]This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose extending the contractual period to December 31, 2019 and resetting of the Exercise Price to $0.25.
  • [F2]Conversion of the previously reported $600,000 Convertible Promissory Note with principal of $600,000 and accrued interest of $149,669.58.
  • [F3]Exercise of the previously reported 3,000,000 warrants.

Documents

1 file

Issuer

OMNI BIO PHARMACEUTICAL, INC.

CIK 0001389870

→
Entity typeoperating
IncorporatedCO

Related Parties

1
  • filerCIK 0001389870

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 6:02 PM ET
Size
22.1 KB
View on SEC.gov